Category: Joint ventures/collaborations
-
Early Space Bio-Experiments Detailed in New Book
A new book by David Warmflash, MD tells about interactions and experiences of humans with the moon, from legends and myths in ancient civilizations to projections for future colonies.
-
CBD Shown Effective Against Staph, Strep Bacteria
Tests of synthetic cannabidiol, or CBD, show the compound is as effective as current antibiotics against a class of microbes that includes Staphyloccocus and Streptococcus bacteria.
-
Energy-Efficient Process Devised for Nano-Emulsions
A more efficient process using less energy is being developed for producing emulsions with tiny droplets to deliver drugs or cosmetics through the skin.
-
Sanofi, Alphabet Partner on A.I., Analytics
Drug maker Sanofi and Alphabet, the parent company of Google, are collaborating on the use of artificial intelligence and analytics for more personalized health care.
-
Challenge Seeks Circular Economy Start-Ups
A challenge competition is seeking new businesses that disrupt the plastics recycling and energy storage industries with ideas based on a circular economy.
-
Intermountain, deCode Partner on Population Genetics
A health care network in Utah is partnering with a genetic analytics company to find connections between genetics and disease in 500,000 of its members.
-
Engineered Antibody Delays Type 1 Diabetes Onset
Results from a clinical trial show a synthetic antibody delayed for about 2 years the start of type 1 diabetes symptoms among people at high risk of the disease.
-
Home Chronic Disease Blood Test in Development
A university chemistry lab and start-up company are developing a home monitoring device that aims to reduce repeated clinic visits by people with chronic diseases.
-
Viral Disease Biotech Joins ElevateBio, Gains $120M
A biotechnology company developing immunotherapies for viral diseases is joining the ElevateBio consortium providing manufacturing for cell and gene therapies.
-
Pharmas Join Digital Clinical Trial Project
Four pharmaceutical companies are signing on to an initiative that promises to make clinical trials friendlier to patients and make better use of digital technology.